Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vigarios

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Annales De Dermatologie Et De Venereologie|June 5, 2016
[Gingival enlargement: Practical management]V Sibaud, E Vigarios, S Tavitian, et al.
Annales De Dermatologie Et De Venereologie|April 25, 2018
[Green tongue phenomenon, or diagnosis via Google]C Godillot, A Laprie, C Eid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
T-DM1-related telangiectasias: a potential role in secondary bleeding eventsV Sibaud, E Vigarios, P Combemale, et al.
Annales De Dermatologie Et De Venereologie|April 22, 2018
[Dermatologic toxicities of immune checkpoint inhibitors]V Sibaud, S Boulinguez, C Pagès, et al.
The British Journal of Dermatology|December 16, 2014
Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitorsE Vigarios, L Lamant, J P Delord, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 19, 2017
Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findingsV Sibaud, C Eid, V R Belum, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2024
Oesophageal lichen planus: Clinical, endoscopic and fibroscopic characteristicsA Kayal, M H Tessier, J-C Fricain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statementZ Apalla, V Nikolaou, D Fattore, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Annales De Dermatologie Et De Venereologie|June 5, 2016
[Gingival enlargement: Practical management]V Sibaud, E Vigarios, S Tavitian, et al.
Annales De Dermatologie Et De Venereologie|April 25, 2018
[Green tongue phenomenon, or diagnosis via Google]C Godillot, A Laprie, C Eid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
T-DM1-related telangiectasias: a potential role in secondary bleeding eventsV Sibaud, E Vigarios, P Combemale, et al.
Annales De Dermatologie Et De Venereologie|April 22, 2018
[Dermatologic toxicities of immune checkpoint inhibitors]V Sibaud, S Boulinguez, C Pagès, et al.
The British Journal of Dermatology|December 16, 2014
Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitorsE Vigarios, L Lamant, J P Delord, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 19, 2017
Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findingsV Sibaud, C Eid, V R Belum, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2024
Oesophageal lichen planus: Clinical, endoscopic and fibroscopic characteristicsA Kayal, M H Tessier, J-C Fricain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statementZ Apalla, V Nikolaou, D Fattore, et al.
Pageof 2